PORTEC‐3 trial finds that adjuvant chemoradiotherapy significantly improves 10‐year survival for patients with high‐risk endometrial cancer

Read full text
Authors: Carrie Printz
Cited by: 0

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Breast Cancer Treatment Studies Esophageal Cancer Research and Treatment

Publication details

Journal / source
CA A Cancer Journal for Clinicians
Volume
76
Issue
1
Pages
e70063–e70063
Publication date
1 January 2026
Language
EN